PROS: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?

Translational Lung Cancer Research, S3(7), p. S287-S289

Translational Lung Cancer Research, S3(7), p. S283-S286

Journal article published in 2018 by Alfredo Addeo

, Giuseppe Luigi Banna

This paper is made freely available by the publisher.

Full text: Download

Preprint: policy unknown

Upload

Postprint: policy unknown

Upload

Published version: policy unknown

Upload